1. Home
  2. QCLS vs CODX Comparison

QCLS vs CODX Comparison

Compare QCLS & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QCLS

Q/C Technologies Inc.

N/A

Current Price

$4.45

Market Cap

14.9M

Sector

Health Care

ML Signal

N/A

Logo Co-Diagnostics Inc.

CODX

Co-Diagnostics Inc.

HOLD

Current Price

$0.27

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QCLS
CODX
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9M
15.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
QCLS
CODX
Price
$4.45
$0.27
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.25
AVG Volume (30 Days)
10.2M
1.6M
Earning Date
11-19-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$507,892.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.23
52 Week High
$158.00
$1.55

Technical Indicators

Market Signals
Indicator
QCLS
CODX
Relative Strength Index (RSI) N/A 38.66
Support Level N/A $0.34
Resistance Level N/A $0.41
Average True Range (ATR) 0.00 0.04
MACD 0.00 -0.00
Stochastic Oscillator 0.00 0.28

Price Performance

Historical Comparison
QCLS
CODX

About QCLS Q/C Technologies Inc.

Q/C Technologies Inc is engaged in building blockchain infrastructure that is faster and more energy-efficient. The company uses laser-based processors inspired by quantum technology that can solve complex problems at the speed of light. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: